Use of spending functions for occasional or continuous monitoring of data in clinical trials.

No abstract is available for this paper.

• Publication year

  1993

• Venue

  Statistics in Medicine

• Publication date

  1993-12-15

• Fields of study

  Medicine, Mathematics

• Identifiers
  DOI 10.1002/SIM.4780122307PMID 8310191
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Sequential monitoring of clinical trials: the role of information and Brownian motion.

  1993cited by this paper
• Effects of vesnarinone on morbidity and mortality in patients with heart failure. Vesnarinone Study Group.

  1993cited by this paper
• Effects of vesnarinone on morbidity and mortality in patients with heart failure

  1993cited by this paper
• Sequential monitoring for comparison of changes in a response variable in clinical studies.

  1992cited by this paper
• Implementation of group sequential logrank tests in a maximum duration trial.

  1990cited by this paper
• Some covariance models for longitudinal count data with overdispersion.

  1990cited by this paper
• Interim analyses with repeated measurements in a sequential clinical trial

  1990cited by this paper
• Group sequential procedures: calendar versus information time.

  1989cited by this paper
• Changing frequency of interim analysis in sequential monitoring.

  1989cited by this paper
• The B-value: a tool for monitoring data.

  1988cited by this paper
• Longitudinal data analysis using generalized linear models

  1986cited by this paper
• Use of logrank tests and group sequential methods at fixed calendar times.

  1985cited by this paper
• Statistical aspects of early termination in the beta-blocker heart attack trial

  1984cited by this paper
• Discrete sequential boundaries for clinical trials

  1983cited by this paper
• Repeated Significance Testing for a General Class of Statistics Used in Censored Survival Analysis

  1982cited by this paper
• Statistical aspects of early termination in the beta-blocker heart attack trial.

  1982cited by this paper
• Two-Sample Repeated Significance Tests Based on the Modified Wilcoxon Statistic

  1982cited by this paper
• A randomized trial of propranolol in patients with acute myocardial infarction. I. Mortality results.

  1982cited by this paper
• Crossing probabilities for a square root boundary by a bessel process

  1981cited by this paper
• A multiple testing procedure for clinical trials.

  1979cited by this paper
• Group sequential methods in the design and analysis of clinical trials

  1977cited by this paper
• Repeated Significance Tests on Accumulating Data

  1969cited by this paper
• An Introduction to Probability Theory and Its Applications

  1959cited by this paper

• Dynamic Monitoring of Ongoing Clinical Trials

  2021cites this paper
• Sequential design and analysis in the randomized clinical trial: A historical perspective

  2020cites this paper
• Transmission reduction and prevention with HPV vaccination (TRAP-HPV) study protocol: a randomised controlled trial of the efficacy of HPV vaccination in preventing transmission of HPV infection in heterosexual couples

  2020cites this paper
• Data Monitoring: Structure for Clinical Trials and Sequential Monitoring Procedures

  2018cites this paper
• Statistical Methods Used in Interim Monitoring

  2015cites this paper
• 13. Recovering Missing or Partial Data from Studies: A Survey of Conversions and Imputations for Meta-analysis

  2013cites this paper
• 5. Extraction and Critical Appraisal of Data

  2013cites this paper
• 22. Power Statistics for Meta-analysis: Tests for Mean Effects and Homogeneity

  2013cites this paper
• 12. Software for Statistical Meta-analysis

  2013cites this paper
• 21. Graphical Presentation of Results

  2013cites this paper
• Monitoring Response Variables

  2010cites this paper
• Return of Chronic Pelvic Pain From Endometriosis After Raloxifene Treatment: A Randomized Controlled Trial

  2008cites this paper
• Designing clinical trials for NOTES.

  2008cites this paper
• Enoxaparin versus unfractionated heparin in the prevention of venous thromboembolism after acute ischemic stroke: rationale, design, and methods of an open-label, randomized, parallel-group multicenter trial.

  2005cites this paper
• Issues in data monitoring and interim analysis of trials.

  2005cites this paper
• Group Sequential Design for Comparative Diagnostic Accuracy Studies: Implications and Guidelines for Practitioners

  2004cites this paper
• Randomised trials comparing chemotherapy regimens for advanced non-small cell lung cancer: biases and evolution over time.

  2003cites this paper
• Design, quality, and bias in randomized controlled trials of systemic lupus erythematosus.

  2003cites this paper
• A trial of the beta-blocker bucindolol in patients with advanced chronic heart failure.

  2001cites this paper
• A TRIAL OF THE BETA-BLOCKER BUCINDOLOL IN PATIENTS WITH ADVANCED CHRONIC HEART FAILURE

  2001cites this paper
• Ethics and Practice

  1999cites this paper
• Modifying the design of ongoing trials without unblinding.

  1998cites this paper
• Group sequential monitoring of distribution-free analyses of repeated measures.

  1997cites this paper
• Ethics and practice: alternative designs for phase III randomized clinical trials.

  1997cites this paper
• Sequential monitoring of clinical trials with correlated responses

  1996cites this paper
• Continuous and group sequential conditional probability ratio tests for phase II clinical trials.

  1996cites this paper
• Sequential monitoring of survival data with the Wilcoxon statistic.

  1995cites this paper
• The alpha spending function approach to interim data analyses.

  1995cites this paper
• , MD , FRCPC , MSc Epid , FASGE * , Peter Cotton , MD , FRCP , FRCS , FASGE

  year unknowncites this paper